Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of paediatric asthma patients

Clinical and Experimental Allergy

Volumn 29, Issue 2, 1999, Pages 176-181

  Gruber, W ^b   Eber, E ^b   Mileder, P ^b   Modl, M ^b   Weinhandl, E ^b   Zach, M S ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b NONE

Author keywords

Asthma; Bronchial responsiveness; Children; House dust mite; Specific immunotherapy

Indexed keywords

ALAVAC; CORTICOSTEROID; CROMOGLYCATE DISODIUM; HOUSE DUST ALLERGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLD AIR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DISEASE CONTROL; DOSE TIME EFFECT RELATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHILD; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOTHERAPY; MALE; MITES; RESPIRATORY FUNCTION TESTS; SKIN TESTS;

EID: 0033006450     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00391.x     Document Type: Article

References (31)

1. 1 Platts-Mills TAE, de Weck AL. Dust mite allergens and asthma - a world wide problem. J Allergy Clin Immunol 1989; 83:416-27.
2. 2 Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-9.
3. 3 Djukanovic R, Roche WR, Wilson JH et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-57.
4. 4 Kerrebijn KF. (ed.) Similarities and discrepancies between asthma and chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:1149-96 and 1419-72.
5. 5 Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978; II.912-5.
6. 6 Bousquet J, Calvayrac P, Guerin B et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985; 76:734-44.
7. 7 Bousquet J, Hejjaoui A, Clauzel AM et al. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II Prediction efficacy immunotherapy. J Allergy Clin Immunol 1988; 82:971-7.
8. 8 Mosbech H, Dreborg S, Frolund L et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract. I. Clinical effect evaluated by diary cards and a retrospective assessment. Allergy 1989; 44:487-98.
9. 9 Van Bever HP, Stevens WJ. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus). Clin Exp Allergy 1989; 19:399-404.
10. 10 Machiels JJ, Somville MA, Lebrun PM et al. Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes. J Clin Invest 1990; 85:1024-35.
11. 11 Van Bever HP, Stevens WJ. Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus). Eur Respir J 1992; 5:318-22.
12. 12 Machiels JJ, Lebrun PM, Jacquemin MG, Saint-Remy JMR. Significant reduction of nonspecific bronchial reactivity in patients with Dermatophagoides pteronyssinus-sensitive allergic asthma under therapy with allergen-antibody complexes. Am Rev Resp Dis 1993; 147:1407-12.
13. 13 Formgren H, Lanner A, Lindholm N, Löwhagen O, Dreborg S. Effects of immunotherapy on specific and non-specific sensitivity of the airways. J Allergy Clin Immunol 1984; 73:140.
14. 14 Murray AB, Ferguson AC, Morrison BJ. Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with immunotherapy. Ann Allergy 1985; 54:541-4.
15. 15 Mosbech H, Dreborg S, Frolund L et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract. II. Effect evaluated by challenges with allergen and histamine. Allergy 1989; 44:499-509.
16. 16 Garcia-Ortega P, Merelo A, Marrugat J, Richart C. Decrease of skin and bronchial sensitization following short-intensive scheduled immunotherapy in mite-allergic asthma. Chest 1993; 103:183-7.
17. 17 Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993; 91:709-22.
18. 18 Galdes-Sebaldt M, McLaughlin FJ, Levison H. Comparison of cold air, ultrasonic mist, and methacholine inhalations as test of bronchial reactivity in normal and asthmatic children. J Pediatr 1985; 107:525-30.
19. 19 Anderson SD, Smith CM. Osmotic challenges in the assessment of bronchial responsiveness. Am Rev Respir Dis 1991; 143:S43-6.
20. 20 Zach M. Cold dry air challenge for measuring bronchial responsiveness - Where do we stand? Pediatr Pulmonol 1995; 19:323-5.
21. 21 National Heart, Lung, Blood Institute National Institutes of Health Bethesda Maryland 20892. International consensus report on diagnosis and treatment of asthma. Eur Respir J 1992; 5:601-41.
22. 22 Zach M, Polgar G, Kump H, Kroisel P. Cold air challenge of airway hyperreactivity in children: practical application and theoretical aspects. Pediatr Res 1984; 18:469-78.
23. 23 Quanjer PH, Tammeling GJ, Cotes JE et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 6 (Suppl. 16):5-40.
24. 24 Hibbert ME, Lannigan A, Landau LI, Phelan PD. Lung function values from a longitudinal study of healthy children and adolescents. Pediatr Pulmonol 1989; 7:101-9.
25. 25 Zach M, Polgar G. Cold air challenge of airway hyperreactivity in children: dose-response interrelation with a reaction plateau. J Allergy Clin Immunol 1987; 80:9-17.
26. 26 Modi M, Eber E, Steinbrugger B, Weinhandl E, Zach MS. Comparing methods for assessing bronchial responsiveness in children: single step cold air challenge, multiple step cold air challenge, and histamine provocation. Eur Respir J 1995; 1742-7.
27. 27 Pliss LB, Ingenito EP, Ingram RH, Pichurko B. Assessment of bronchoalveolar cell and mediator response to isocapnic hyperpnea in asthma. Am Rev Respir Dis 1990; 142:73-8.
28. 28 Price JF, Warner JO, Hey EN, Turner MW, Soothill JF. A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects. Clin Allergy 1984; 14:209-19.
29. 29 Van Bever HP, Stevens WJ. Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy. J Allergy Clin Immunol 1990; 86:141-6.
30. 30 Des Roches A, Paradis L, Knani J et al. Immunotherapy with standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy 1996; 51:430-3.
31. 31 Hedlin G, Heilborn H, Lilja G et al. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995; 96:879-85.